Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The history now shows that the study is no longer recruiting participants, and the record has been updated to revision v3.6.0, with the previous revision v3.5.5 removed.
    Difference
    0.3%
    Check dated 2026-06-12T11:26:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision (v3.5.5) was added to the history and the previous revision (v3.5.4) was removed, updating the study record history on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-06-05T08:37:06.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the study record history, while the previous revision v3.5.3 was removed from the visible list, reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-05-14T22:27:14.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s footer/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting an internal release or interface revision.
    Difference
    0.1%
    Check dated 2026-04-23T22:08:20.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T18:36:36.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:18:52.000Z thumbnail image

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.